About
Honey Bee Venom
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
871
By Phase
PHASE3: 2PHASE2: 1
By Status
COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT03710655Lead Sponsor
Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients
PHASE3Unknown
468 participants
Started: Apr 30, 2019 · Completed: Nov 30, 2019
NCT01112722Lead Sponsor
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
PHASE3Completed
363 participants
Started: Dec 31, 2013 · Completed: Dec 31, 2016
NCT00949754Lead Sponsor
Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation
PHASE2Completed
40 participants
Started: Oct 31, 2009 · Completed: Apr 30, 2010
Locations (1)
Headquarters
Matawan, NJ, United States
Map
Loading map...